This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and pharmacodynamics of SB-656933 following single dose administration in subjects with CF.
Showing the most recent 10 out of 724 publications